Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of Steris (NYSE: STE ) �-- a manufacturer of infection prevention, contamination control, and surgical support products for the health-care industry -- jumped as much as 10% after reporting better-than-expected fourth-quarter results.
So what: For the quarter, Steris' shareholders witnessed revenue increase by 10% to $428.2 million as EPS shrank modestly to $0.70 from $0.76 in the year-ago period. Although Steris blamed European weakness and the medical device excise tax for its weaker bottom-line results, both figures topped the $406 million in revenue and $0.65 in EPS that the Street had been expecting. The biggest boost came from the company's life sciences segment, which saw operating income grow by 14%. For the upcoming year, Steris issued guidance calling for revenue growth of 8%-10% (implying $1.62 billion to $1.65 billion) and EPS of $2.47-$2.60. Current consensus estimates are for revenue of $1.57 billion and EPS of $2.49.
10 Best Life Sciences Stocks To Buy Right Now: Kawasaki Heavy Industries Ltd (KWHIY)
Kawasaki Heavy Industries Ltd (KHI), incorporated on October 15, 1896, is a global manufacturer of transportation equipment and industrial goods. KHI manufactures ships, rolling stock, aircraft and jet engines, gas turbine power generators, environmental and industrial plants, and range of manufacturing equipment and systems. KHI also produces consumer products, such as Kawasaki-brand motorcycles and personal watercraft. KHI�� business is divided into seven operations: shipbuilding, rolling stock and construction machinery, aerospace, gas turbines and machinery, plant and infrastructure engineering, consumer products and machinery, and hydraulic machinery.
Kawasaki Shipbuilding Corporation, which is the company of this segment, is engaged in building gas carriers and submarines, which require advanced design and construction technologies. It offers
a range of liquefied natural gas (LNG) carriers, extending from small carriers with cargo tank capacities of 19,000 cubic meters to large carriers with capacities of 177,000 cubic meters. It also developed and offered in its lineup a pressure build-up type LNG carrier for short distance and small-volume transportation. The Company�� shipbuilding operations include products, such as LNG carriers, liquefied petroleum gas (LPG) carriers, container ships, very large crude carriers (VLCCs) and other types of tankers, bulk carriers, high speed vessels, submarines, maritime application equipment.
KHI�� rolling stock production systems are located in Hyogo and Harima in Japan and in Lincoln, Nebraska, and Yonkers, New York, in United States. Kawasaki completed its light rail vehicle (LRV), dubbed SWIMO. It also is developing efSET (Environmentally Friendly Super Express Train) which achieves a service speed of 350 kilometers per hour (km/h). Regarding the construction machinery business, Kawasaki has arranged a business alliance with Hitachi Construction Machinery Co., Ltd., and TCM Corporation. As of April 1, 2009, the Compa! ny split off its construction machinery business as a wholly owned subsidiary of KHI, KCM Corporation.
KHI is the prime contractor for the development of the MOD�� large-scale XP-1 and C-X aircraft. In the commercial aircraft field, KHI delivered a test model of Boeing�� 787 Dreamliner passenger aircraft. KHI is a partner corporation in the development and production of the 787 Dreamliner.
The Gas Turbines & Machinery segment has a range of products for the energy and transportation equipment field. KHI focuses to expand its global business by offering solutions for its customers that include a lineup of in-house developed gas turbines together with product support and maintenance. During the year ended December 31, 2008, the 8MW-class power-generating capacity Kawasaki Green Gas Engine had 4,000 hours of operational testing.
The plant and infrastructure engineering segment encompasses the operations of Kawasaki Plant Systems, Ltd. (K Plant), which undertakes projects to supply energy-related, industrial infrastructure, environmental preservation systems and equipment, and the operations of the parent company�� Industrial Facilities and Tunneling Equipment Division, which mainly focuses on LNG tanks and diverse other storage tanks along with shield machines and tunnel-boring machines. The Anhui Conch Kawasaki Energy Conservation Equipment Manufacturing Co., Ltd. (CKM) is engaged in the manufacturing of PH boiler parts that are employed in waste heat power plants. CKM has commenced the manufacturing and sales of environmental preservation related products, including cement plant components, such as vertical mills, boilers for waste heat recovery power generation systems, and waste gasification systems and sewage treatment systems that can be integrated with cement kilns to enable municipal waste recycling.
The consumer products and machinery segment includes the manufacture of motorcycles, all terrain vehicles (ATVs), utility vehicles, personal! watercra! ft, general purpose gasoline engines and industrial robots. In the motorcycle line, Kawasaki launched the ZRX1200 DAEG and the Ninja ZX-6R. In the cruiser segment, Kawasaki launched its Vulcan 1700 series with developed engine and chassis. This series includes the Vulcan 1700 Voyager, a full-dress V-twin engine tourer with a load of long-distance touring equipment. In the utility vehicle category, KHI equipped the Teryx 750 series with an electronic fuel injection system, mainly for recreational use. The MULE utility-oriented vehicle series was restyled with the launch of the MULE 4010 series.
The hydraulic machinery operations include Kawasaki Precision Machinery Ltd. (KPM). It has five manufacturing and marketing facilities, which comprises KPM�� headquarters plant and the facilities
of Kawasaki Precision Machinery (U.K.) Limited; Kawasaki Precision Machinery (U.S.A.), Inc.; China based Kawasaki Precision Machinery (Suzhou) Ltd.; and Korea-based Flutek, Ltd.
Advisors' Opinion:- [By WWW.MARKETWATCH.COM]
LOS ANGELES (MarketWatch) -- Japanese stocks have ended with losses in every session this week, and sure enough, the Nikkei Average (JP:NIK) was down 0.6% in early Friday trade, though off an opening 0.8% defecit, while the Topix carried a 0.7% loss. Overnight losses for the U.S. and further strength in the yen (with the dollar falling to 楼101.28 from 楼101.56 a day earlier) helped drag the market lower, as did results from Fast Retailing Co. (JP:9983) (FRCOF) , the shares of which hold the heaviest weighting on Nikkei Average. Fast Retailing said that while its Uniqlo brand was doing great business, weakness for its J Brand luxury demin label helped send September-May profit down 4% and prompted another cut to Fast's full-year outlook. Consequently, its shares traded 0.7% lower, though rivals Takashimaya Co. (JP:8233) and J. Front Retailing Co. (JP:3086) (JFROF) also saw losses of 0.6% and 0.5%, respectively. Among other decliners, Sony Corp. (JP:6758) (SNE) lost 0.7%, Toshiba Corp. (JP:6502) (TOSYY) fell 2.1%, Kawasaki Heavy Industries Ltd. (JP:7012) (KWHIY) fell 1.5%, Toyota Motor Corp. (JP:7203) (TM) and Nissan Motor Co. (JP:7201)
10 Best Life Sciences Stocks To Buy Right Now: RAIT Financial Trust(RAS)
RAIT Financial Trust operates as a self-managed and self-advised real estate investment trust (REIT). The company, through its subsidiaries, invests in, manages, and services real estate-related assets with a focus on commercial real estate. It also offers a set of debt financing options to the commercial real estate industry along with fixed income trading and advisory services. In addition, RAIT Financial Trust owns and manages a portfolio of commercial real estate properties, and manages real estate-related assets for third parties. The company qualifies as a REIT for federal income tax purposes. As a REIT, it would not be subject to federal income tax to the extent that it distributes at least 90% of its taxable income to its shareholders. RAIT Investment Trust was founded in 1997 and is based in Philadelphia, Pennsylvania.
Advisors' Opinion:- [By Thomas Sobon]
Instead of expressing my thoughts in vague generalities, let me be specific and tell you what I am actually doing on a real time basis to cope with the market dynamics occurring right now: I have a core position in one stock, which is the RAIT Financial Trust (RAS). Its size is about 60% of what I would consider to be a "full" position. I also have a lot of cash that I intend to use for trading purposes. Last Friday I sold shares of RAS at $7.55 which I bought on Monday with a low-ball bid of $7.11, so my gain on the trade was 6.2%. In early trading yesterday (Monday July 1) RAS is priced at $7.67, up from where I sold on Friday. That's great news because I accomplished what I wanted to do with the trade and now paper profit on the core shares in my portfolio is increasing.
- [By Eric Volkman]
RAIT Financial Trust (NYSE: RAS ) investors will be getting slightly more than they did last quarter, as a reward for putting their faith in the company (NYSE: RAS ) . The real estate investment trust has declared a common stock dividend of $0.13 per share, to be handed out on July 31 to shareholders of record as of July 12.�That amount is $0.01, or 8%, higher than RAIT's previous distribution of $0.12, which was paid in April. Prior to that, the firm dispensed $0.10 per share.
- [By Marc Bastow]
Commercial real estate holding real estate investment trust (REIT) RAIT Financial (RAS) raised its quarterly dividend 7% to 16 cents per share, payable on Jan. 31 to share holders of record as of Jan. 7.
RAS Dividend Yield: 7.48%
Top Electric Utility Companies To Buy For 2015: Choice Hotels International Inc. (CHH)
Choice Hotels International, Inc., together with its subsidiaries, operates as a hotel franchisor worldwide. It franchises lodging properties under its proprietary brand names, including Comfort Inn, Comfort Suites, Quality, Clarion, Sleep Inn, Econo Lodge, Rodeway Inn, MainStay Suites, Suburban Extended Stay Hotel, Cambria Suites, and Ascend Collection brands. As of March 31, 2011, it operated 6,128 open hotels comprising 492,733 rooms, as well as 606 hotels consisting of 49,908 rooms under construction, awaiting conversion, or approved for development in 49 states, and the District of Columbia in the United States; and approximately 40 countries and other territories. The company was founded in 1981 and is based in Silver Spring, Maryland.
Advisors' Opinion:- [By WWW.DAILYFINANCE.COM]
Getty Images From a door-to-door selling icon stocking up on blush after a disappointing quarter to several hotel chains checking in with strong occupancy trends, here's a rundown of the week's smartest moves and biggest blunders in the business world. Hotels -- Winners Hoteliers were apparently hopping during the first quarter. Despite the iffy weather and the equally iffy economy, the leading chains reporting this week posted surprisingly robust activity. Revenue per available room is a key metric because it tracks occupancy levels as well as prevailing overnight rates. The industry's doing well when RevPAR is positive, and that's just what we saw with this week's reports. Choice Hotels (CHH), Marriott (MAR), and Hyatt (H) clocked in with RevPAR increases of 5.6 percent, 6.3 percent and 6.5 percent, respectively. Twitter (TWTR) -- Loser Shares of Twitter hit an all-time low this week after the company posted disappointing user growth. Sure, the "all-time low" remark needs to be accompanied by the caveat that Twitter has only been trading publicly for less than six months. It's still a grim milestone for last year's most anticipated debutante. Twitter's revenue growth was fine, propelled by the recent success of its monetization initiatives. Its outlook was upbeat. However, the one thing that haunted investors this week was that Twitter had just 14 million more unique monthly visitors than it had a quarter earlier. That kind of sequential uptick would've impressed at most companies, but Twitter trades at a juicy premium to the market. #Letdown. J.C. Penney (JCP) -- Winner The struggling department store operator isn't out of the woods just yet, but at least one supplier is offering up encouraging insight. PVH (PVH) was presenting at an investor conference in Miami earlier in the week when its CEO offered up an encouraging perspective. "The Penney's business is running on or ahead of plan and given what their sales trends are," said CEO Manny Chirico,
- [By John Udovich]
Small cap hotel stock La Quinta Holdings Inc (NYSE: LQ) just had its IPO to raise a lower than expected $650 million after being priced below its expected range, meaning its worth taking a closer look at the stock which�is focused on the�mid-priced hotel market along with the performance of potential benchmarks like hotel stocks Marriott International Inc (NASDAQ: MAR), Choice Hotels International Inc (NYSE: CHH) and Wyndham Worldwide Corporation (NYSE: WYN).
- [By Sean Williams]
Don't make the wrong Choice
I predict that 2013 will be the return of the "staycation." In the depths of the recession, instead of taking expensive getaways, consumers chose simply to take time off work and stay home or locally. I think we have the perfect confluence of factors that could make life difficult for Choice Hotels International (NYSE: CHH ) , operator of Comfort Inn, Comfort Suites, and a multitude of other mid-price-point hotels. - [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Choice Hotels International (NYSE: CHH ) , whose recent revenue and earnings are plotted below.
10 Best Life Sciences Stocks To Buy Right Now: Bovie Medical Corporation (BVX)
Bovie Medical Corporation develops, manufactures, and markets medical products and devices with an emphasis on electrosurgical generators and electrosurgical disposables primarily in the United States. Its electrosurgery product line comprises desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used in surgical procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue. The company offers Aaron 900 and Aaron 940, which are high frequency desiccators designed primarily for dermatology and family practice physicians for removing small skin lesions and growths, as well as for office based coagulation. It also provides Aaron 950, a high frequency desiccator with cut capacity for outpatient surgical procedures; Aaron 1250U, a 120-watt multipurpose electrosurgery generator; and Aaron 2250/3250 and IDS 200/300/400 multipurpose digital electros urgery generators. In addition, the company offers ICON GI, ICON GP, and ICON VS specialty electrosurgical generators; Resistick II, a coating that is applied to stainless steel, which resists eschar during surgery; disposable laparoscopic instruments; and ICON GS (J-Plasma), a plasma system. Further, it provides battery operated cauteries used for sculpting woven grafts in bypass surgery, vasectomies, and evacuation of subungual hematoma, as well as for arresting bleeding in various types of surgeries; battery operated medical lights that act as specialty lighting instruments for use in ophthalmology as well as specialty lighting instruments for general surgery, hip replacement surgery, and for the placement of endotracheal tubes in emergency and surgical procedures; and nerve locator stimulators used for identifying motor nerves in hand and facial reconstructive surgery. Bovie Medical Corporation was founded in 1982 and is based in Melville, New York.
Advisors' Opinion:- [By Andrew Stephan]
The J-Plasma surgical technology from Bovie Medical Corporation (BVX) has recently begun to hit the market. Although it is anticipated sales will start out slowly due to the time involved in building and deploying a sales force specific to J-Plasma and in hospital capital equipment purchasing decisions, revenues from J-Plasma are expected to become very strong in 2014, leading to a correspondingly large upward move in the share price.
10 Best Life Sciences Stocks To Buy Right Now: G&K Services Inc (GK)
G&K Services, Inc., incorporated on December 1, 1934, provides branded uniform and facility services programs. The Company serves a base of approximately 170,000 customers. The Company serves customers in all industries, including automotive, warehousing, distribution, transportation, energy, manufacturing, food processing, pharmaceutical, retail, restaurants, hospitality, government, healthcare and many others. The Company provides service to customers of almost every size, from Fortune 100 companies to small and midsize firms. The Company has one million people within its customer base who wear G&K work apparel every work day. In January 2014, the Company announced that it has sold its direct sale program business.
The Company's customer focused relationships involve customers renting or directly purchasing uniforms and providing facility products and services to meet a variety of critical needs in the workplace, including Image, Organization safety and security, Brand awareness, Employee retention, Employee protection and Product protection. The Company also offers facility services programs that provide a range of dust control, maintenance, hand care and hygiene products and services. They include floor mat offerings (traction control, logo, message, scraper, anti-fatigue), towel products (shop, kitchen, bar, bath, dish, continuous roll, microfiber), mop offerings (dust, microfiber, wet), fender covers, selected linen items and restroom hygiene products. The Company's providing of regularly scheduled weekly service of these products and services helps the Company's customers maintain a clean, safe and attractive environment within their facilities for their employees and customers.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on G&K Services (Nasdaq: GK ) , whose recent revenue and earnings are plotted below.
10 Best Life Sciences Stocks To Buy Right Now: Brookfield Residential Properties Inc (BRP)
Brookfield Residential Properties Inc. (Brookfield Residential) is a land developer and homebuilder.The Company entitles and develops land and builds homes for its own communities, as well as sells lots to third-party builders. It operates in three segments in North America: Canada, California and Central and Eastern U.S. Each of the Company�� segments specializes in lot entitlement and development and the construction of single-family and multi-family homes. As of December 31, 2011, Brookfield Residential controlled 108,197 lots. The Company became a public company on March 31, 2011, by combining the former business of Brookfield Homes Corporation (Brookfield Homes) and the residential land and housing division (BPO Residential) of Brookfield Office Properties Inc. into a single residential land and housing company, achieved through a merger and series of related transactions completed on March 31, 2011. Advisors' Opinion:- [By Ben Levisohn]
In terms of specific company upside/downside payoffs, we believe that [Brookfield Residential Properties (BRP)], [KB Home], and [PulteGroup] offer above-average payoffs. We note that more than half of [Brookfield Residential Properties'] earnings are derived from Canada, dampening EPS sensitivity to our assumptions regarding the pace of the U.S. housing recovery. We believe that [KB Home] will achieve sharply improved operating performance, which should drive robust EPS growth given the company�� comparatively high degree of financial leverage. We also have a high degree of confidence that�[PulteGroup] will continue to successfully execute against its goal of improving ROIC performance, which should act as a catalyst for share price appreciation.
10 Best Life Sciences Stocks To Buy Right Now: Marsh & McLennan Companies Inc. (MMC)
Marsh & McLennan Companies, Inc., a professional services company, provides advice and solutions in the areas of risk, strategy, and human capital. It operates in two segments, Risk and Insurance Services, and Consulting. The Risk and Insurance Services segment provides risk management and insurance broking, reinsurance broking, and insurance program management services for businesses, public entities, insurance companies, associations, professional services organizations, and private clients. The Consulting segment offers advice and services to the managements of organizations in the area of human resource consulting, comprising retirement and investments, health and benefits, outsourcing and talent; and strategy and risk management consulting, such as management, economic, and brand consulting. The company also provides investment consulting services for endowments and foundations in the United States; health and benefit recordkeeping, and employee enrollment technology; human resource knowledge, data, and solutions for professionals in various industries; and Medicaid policy consulting services. It principally serves customers in the United States, the United Kingdom, the Asia Pacific, and Continental Europe. Marsh & McLennan Companies, Inc. was founded in 1871 and is headquartered in New York, New York.
Advisors' Opinion:- [By CRWE]
Marsh & McLennan Companies, Inc. (NYSE:MMC) held its annual meeting of shareholders, at which the Company announced that its Board of Directors has voted to increase the Company�� quarterly cash dividend by 5 percent to $.23 per share on outstanding common stock.
- [By Christina Rexrode]
Marsh & McLennan Cos Inc. (MMC) and MetLife Inc. (MET) have been rising since those companies reported earnings earlier this week.
- [By Ben Levisohn]
Progressive (PGR) was downgraded from Strong Buy to Market Perform at Raymond James, while Marsh & McLennan (MMC) was cut to Outperform from Strong Buy.
- [By Keith Speights]
Flourishing
While the federal Obamacare exchanges flail, private health insurance exchanges are flourishing. For example,�Mercer, a subsidiary of Marsh & McLennan Companies (NYSE: MMC ) ,�announced in April that several large insurers -- including Aetna, Cigna, Humana, and UnitedHealthcare -- would be part of its Mercer Marketplace private exchange. Mercer Marketplace allows employers to contribute a defined amount for its employees to use on health coverage. Employees use the system to shop around for the insurance plans that best meet their needs.
10 Best Life Sciences Stocks To Buy Right Now: Sa Sa International Holdings Ltd (SAXJF)
Sa Sa International Holdings Limited is an investment holding company. The Company�� subsidiaries are principally engaged in the retailing and wholesaling of cosmetic products. Its business covers Hong Kong and Macau, Mainland China, Taiwan, Singapore, and Malaysia. The Company operates in two segments: retail segment, engaged in the operation of cosmetics specialty stores, which offer a variety of products from over 600 beauty brands, covering a wide of products from skin care, fragrance, make-up, body care and hair care to health foods, and brand management segment, engaged in the management of over 100 beauty brands. It also offers round-the-clock online shopping services along with product and corporate information through its e-commerce platform, sasa.com. The Company�� subsidiaries include Alibaster Management Limited, Base Sun Investment Limited, Cyber Colors Limited, Docile Company Limited and Elegance Trading (Shanghai) Company Limited, among others. Advisors' Opinion:- [By WWW.MARKETWATCH.COM]
HONG KONG (MarketWatch) -- Hong Kong stocks swung between small gains and losses early Thursday after hitting a seven-month high in the previous session, with the Hang Seng Index (HK:HSI) down less than 0.1%. Most mainland Chinese property developers outperformed the markets, with Guangzhou R&F Properties Co. (HK:2777) (GZUHF) rallying 3.4%, after the company reported a 44% month-on-month jump in sales for June. Shimao Property Holdings Ltd. (HK:0813) (SIOPF) climbed 2.6%, and China Resources Land Ltd. (HK:1109) (CRBJF) rose 1.7%. However, several retailers were weak, as Want Want China Holdings Ltd. (HK:0151) (WWNTF) , the country's top food and beverage maker, declined 2%. Hong Kong-based cosmetics brand Sa Sa International Holdings (HK:0178) (SAXJF) fell 1.6%, with a decline in Chinese June non-manufacturing data helping weigh on some retailers. Over on the Chinese mainland, the Shanghai Composite Index (CN:SHCOMP) retreated 0.4%, pulling back from its highest close in two weeks.
10 Best Life Sciences Stocks To Buy Right Now: Box Ships Inc.(TEU)
Box Ships Inc. owns and operates containerships. As of August 16, 2011, it operated a fleet of 7 containerships with a total carrying capacity of 33,237 twenty-foot equivalent units. The company was founded in 2010 and is based in Athens, Greece.
Advisors' Opinion:- [By Monica Gerson]
Box Ships (NYSE: TEU) shares fell 20.38% to reach a new 52-week low of $1.90 after the company priced 5 million units at $2.05 per unit.
Toyota Motor (NYSE: TM) shares reached a new 52-week low of $104.90. Toyota shares have dropped 4.90% over the past 52 weeks, while the S&P 500 index has gained 17.50% in the same period.
- [By Monica Gerson]
Box Ships (NYSE: TEU) slipped 18.49% to $1.94 after the company priced 5 million units at $2.05 per unit.
China Auto Logistic (NASDAQ: CALI) shares dropped 9.06% to $3.17 after the company announced 2013 results. China Auto Logistic posted its net income of $524,260, or $0.14 per share.
- [By Eric Volkman]
TearLab (NYSE: TEU ) is looking to widen its capital base by more than $32 million in an underwritten public offering of its common stock. The company is floating 2.6 million shares at a price of $13.50 apiece. Additionally, the company's underwriters have been granted a 30-day purchase option for up to an additional 15% of the total number of shares to cover overallotments.
10 Best Life Sciences Stocks To Buy Right Now: Neuralstem Inc (CUR)
Neuralstem, Inc., incorporated in 1997, is a development-stage company focused on the development and commercialization of treatments for central nervous system disease based on transplanting human neural stems cells and the use of small molecule drugs. The Company has developed and maintains a portfolio of patents and patent applications that form base for its research and development efforts in the area of neural stem cell research. The Company's focus is the development of methods to generate replacement cells from neural stem cells.
In October of 2011, the Company announced that after reviewing safety data from the first 12 patients, the FDA granted approval for the trial to advance to transplanting patients in the cervical (upper back) region for the last six patients in the trial. As of December 31, 2011, the Company had treated 14 patients. In February of 2011, the Company commenced a Phase Ia clinical trial of its drug compound, NSI-189, which is being developed for the treatment of depressive disorder and other psychiatric indications. In October of 2011, the Company completed the Phase Ia portion of the trial. In December of 2011, the Company received approval from the FDA to commence the Phase Ib portion of the trial.
During the year ended December 31, 2011, the Company was selected as the primary subcontractor for the United States Department of Defense (DOD) contract to develop human neural stem cell technology for the treatment of cancerous brain tumors. The Company commenced work on the project in May 2011. The Company has developed and patented a series of small molecule compounds (low molecular weights organic compounds which can efficiently cross the blood/brain barrier).
Advisors' Opinion:- [By Roberto Pedone]
Neuralstem (CUR) is a biotechnology company, which is engaged in the development and commercialization of treatments for central nervous system disease based on transplanting human neural stem cells and the use of small molecule drugs. This stock closed up 6.1% to $1.72 in Thursday's trading session.
Thursday's Range: $1.59-$1.72
52-Week Range: $0.49-$1.96
Thursday's Volume: 590,000
Three-Month Average Volume: 474,694From a technical perspective, CUR ripped higher here right above its 50-day moving average of $1.57 with above-average volume. This move is quickly pushing shares of CUR within range of triggering a major breakout trade above a former double top area. That trade will hit if CUR manages to take out some near-term overhead resistance levels at $1.75 to $1.79 with high volume.
Traders should now look for long-biased trades in CUR as long as it's trending above its 50-day at $1.57 or above more key support levels at $1.55 to $1.43 and then once it sustains a move or close above those breakout levels with volume that hits near or above 474,694 shares. If that breakout hits soon, then CUR will set up to re-test or possibly take out its 52-week high at $1.96. Any high-volume move above that level will then give CUR a chance to tag $2.20 to $2.50.
- [By John Udovich]
The results of a recent Pew Center Poll regarding attitudes towards abortion and various forms of stem cell research could be a good sign for the stem cell industry along with small cap stem cell stocks like StemCells Inc (NASDAQ: STEM), NeoStem Inc (NASDAQ: NBS), Neuralstem, Inc (NYSEMKT: CUR),�International Stem Cell Corp (OTCMKTS: ISCO) and BioRestorative Therapies (OTCBB: BRTX). Basically, Americans think that having an abortion is a moral issue with 49% of American adults believing abortion is morally wrong, 23%�view it not as a moral issue and and 15% view it as morally acceptable. However and when Americans were asked about issues surrounding�human embryos, such as stem cell research or in vitro fertilization, as a matter of morality, their views were different.
- [By James E. Brumley]
Nine times out of ten, I'd be hesitant to be bullish on a stock that's already made a 57% run up in just five months. Neuralstem, Inc. (NYSEMKT:CUR) is that one out of ten instances though, where there's plenty more room ahead to keep on running. In fact, I think CUR could almost double in value from where it is now before the rally effort ran out of gas.
- [By GuruFocus]
George Soros (Trades, Portfolio) just reported his first quarter portfolio. He buys Citrix Systems Inc, Baker Hughes Inc, Comcast Corp, Spansion Inc, etc during the 3-months ended 03/31/2014, according to the most recent filings of his investment company, Soros Fund Management LLC. As of 03/31/2014, Soros Fund Management LLC owns 305 stocks with a total value of $10.1 billion. These are the details of the buys and sells.New Purchases: BHI, CODE, CTRP, CLI, AVB, COMM, CNQ, AGO, AUY, ATML, ASH, BXMT, CSTM, AEM, CMA, ARE, CHKP, AUQ, BEAV, CX, ADSK, AALCP, BLK, AIG, BIIB, ADEP, AMRI, ARWR, ATHX, BALT, BCRX, BEAT, CFX, CLFD, CUR, CODE,Added Positions: CTXS, CMCSA, CNP, ALTR, BRCD, CBS, CRM, CHTR, CCJ, CIEN, BIDU, ALLE, ABT, CDNS, ACT,Reduced Positions: AAPL, CCI, AMT, ABBV, AAL, BITA, AL, ANGI, ARIA, CBST, BA, BIRT, EXAR,Sold Out: C, BAC, CRI, AMZN, AGN, CF, BRCM, COTY, BMY, AMCX, CAR, A, ADBE, AFL,For the details of George Soros (Trades, Portfolio)'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=George+SorosThis is the sector weightings of his portfolio:Technology18.9%Energy14%Healthcare8.3%Consumer Defensive8.2%Communication Services8.1%Consumer Cyclical5.4%Industrials5.1%Basic Materials4.9%Financial Services2.5%Real Estate1.9%Utilities0.5%These are the top 5 holdings of George Soros (Trades, Portfolio)1. Teva Pharmaceutical Industries Ltd (TEVA) - 10,310,041 shares, 5.4% of the total portfolio. Shares added by 10.67%2. Herbalife Ltd (HLF) - 4,901,337 shares, 2.8% of the total portfolio. Shares added by 52.9%3. EQT Corp (EQT) - 2,573,814 shares, 2.5% of the total portfolio. Shares added by 3.27%4. Adecoagro SA (AGRO) - 25,915,076 shares, 2.1% of the total portfolio.5. Halliburton Co (HAL) - 3,596,353 shares, 2.1% of the total portfolio. Shares reduced by 20.73%New Purchase: Baker Hughes Inc (BHI)George Soros (Trades, Portfolio) initiated holdings in Baker Hughes Inc. His purchase prices were between $51.82 and $65.27, with an estimated
No comments:
Post a Comment